Metabolism & Elimination The metabolic fate of Syn-AKE remains incompletely characterized, though general peptide degradation pathways likely apply: Enzymatic degradation through peptidases in skin tissue and systemic circulation Rapid clearance expected based on small peptide structure Half-life estimates not well-established in human studies Minimal systemic accumulation expected with topical application A notable characteristic is the duration-potency disconnect : despite presumed rapid peptide degradation, effects on muscle contractility persist for hours after single applications and cumulative effects develop over weeks, suggesting either tissue retention, formation of active metabolites, or triggering of persistent signaling cascades
PMID: 40672312 Solvent & Solubility In Vitro : DMSO : 140 mg/mL ( 465.98 mM
Reid, S., Lu, C., Hardy, N., Casikar, I., Reid, G., Cario-Toumaniantz, C., & Condous, G
Modalities: Physical therapy modalities (ultrasound, electrical stimulation, laser therapy) may complement peptide effects though evidence for synergy lacking
